Allergen-Specific Immunotherapy Against Allergic Respiratory Diseases / 대한내과학회지
Korean Journal of Medicine
; : 370-376, 2020.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-894523
Responsible library:
WPRO
ABSTRACT
Allergen-specific immunotherapy (AIT) can alter the natural course of an allergic disease. It is widely held that the efficacy of a given therapeutic modality should be proven by well-designed double-blind placebo-controlled randomized clinical trials and meta-analyses. In this article, the therapeutic efficacy of AIT for allergic respiratory diseases, such as allergic rhinitis and asthma, is reviewed. In addition, potential clinical and experimental predictors of the treatment response are reviewed for AITs requiring long-term treatment, and for some allergic rhinitis and asthma patients who show no response to AIT.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2020
Document type:
Article